In glioma cell lines, reintroducing Peg3 abrogates Wnt signaling by promoting degradation of β-catenin via the proteasome in a non-canonical pathway that is independent of glycogen synthase kinase 3β (42). The gene discussed is PEG3; the disease is glioma.